Literature DB >> 25645583

Procedure-related bleeding in elective percutaneous coronary interventions.

Gjin Ndrepepa1, Tilman Stephan, Katrin Anette Fiedler, Elena Guerra, Sebastian Kufner, Adnan Kastrati.   

Abstract

BACKGROUND: Prognostic impact of procedure-related bleeding in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI) remains incompletely investigated. The aim of this study was to investigate the association between peri-PCI bleeding and 1-year outcome of patients with stable CAD.
MATERIALS AND METHODS: The study included 9035 patients with stable CAD who underwent elective PCI. Bleeding within 30 days of PCI was defined using the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 1-year mortality.
RESULTS: Bleeding occurred in 844 patients (9.3%). Actionable bleeding (BARC class ≥ 2) occurred in 442 patients (4.9%). There were 210 deaths (2.3%) at 1 year following PCI: 41 deaths among patients with bleeding and 169 deaths among patients without bleeding [Kaplan-Meier estimates of mortality, 4.9% and 2.1%; odds ratio = 2.41, 95% confidence interval (CI) 1.73-3.36, P < 0.001]. The association between bleeding and mortality remained significant after adjustment for baseline risk variables (adjusted hazard ratio = 1.87, 95% CI 1.27-2.76, P = 0.002). Bleeding increased the discriminatory power of the model regarding prediction of 1-year mortality (absolute and relative integrated discrimination improvement, 0.006% and 16.3%, respectively, P = 0.001).
CONCLUSIONS: In patients with stable CAD undergoing elective PCI, the occurrence of bleeding within 30 days of the procedure was associated with increased risk of death at 1 year after PCI. These findings suggest that procedure-related bleeding may contribute to less than optimal results of PCI in terms of mortality reduction in patients with stable CAD.
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Bleeding; mortality; myocardial infarction; percutaneous coronary intervention; stable coronary artery disease

Mesh:

Substances:

Year:  2015        PMID: 25645583     DOI: 10.1111/eci.12408

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  1 in total

1.  Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter.

Authors:  Shqipdona Lahu; Peter Bristot; Senta Gewalt; Alexander Goedel; Daniele Giacoppo; Stefanie Schüpke; Heribert Schunkert; Adnan Kastrati; Nikolaus Sarafoff
Journal:  J Atheroscler Thromb       Date:  2021-07-10       Impact factor: 4.394

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.